Research library / Omega-3

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

D Bhatt, P Steg, M Miller, E Brinton, T Jacobson, S Ketchum et al.. New England Journal of Medicine. 2019.

Published 2026-10-15Sources checked 2026-10-151 sourceEverstack research teamHow we work

In plain language

REDUCE-IT: 4 g per day of prescription EPA lowered ischemic events by about 25% in statin-treated patients with high triglycerides.

Limits

Mineral oil placebo may have raised control-group risk; industry funded; a drug, not a supplement.

Source

doi.org/10.1056/NEJMoa1812792 · PubMed 30415628

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.